# A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China

> **NCT01278433** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 5007 (actual)

## Conditions studied

- Polio
- Poliomyelitis

## Interventions

- **BIOLOGICAL:** IMOVAX Polio™: Inactivated Poliomyelitis Vaccine

## Key facts

- **NCT ID:** NCT01278433
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 5007 (ACTUAL)
- **Last updated:** 2013-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01278433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01278433, "A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01278433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*